Which demographic is at higher risk for developing angioedema as a side effect of ACE inhibitors?

Which demographic is at higher risk for developing angioedema as a side effect of ACE inhibitors?

• A. Caucasians
• B. Hispanic individuals
• C. Black people
• D. Asians

Answer: (C)

The demographic that is at higher risk for developing angioedema as a side effect of ACE inhibitors is Black people. This increased susceptibility is associated with genetic factors and the way certain populations metabolize medications. Research has shown that Black patients are more likely to experience angioedema compared to other ethnic groups when taking ACE inhibitors, which are commonly prescribed for hypertension and heart failure. Angioedema is a potentially serious condition characterized by rapid swelling of the dermis, subcutaneous tissue, and mucosal tissues. The risk associated with ACE inhibitors can be attributed to their mechanism of action, which influences the renin-angiotensin-aldosterone system. The resulting accumulation of bradykinin, a peptide that increases vascular permeability, plays a significant role in the development of angioedema. While angioedema does occur among individuals of all ethnic backgrounds, the heightened prevalence and severity in Black individuals necessitate careful monitoring when these medications are prescribed. This understanding allows healthcare providers to make informed decisions about treatment options and patient management.

The demographic that is at higher risk for developing angioedema as a side effect of ACE inhibitors is Black people. This increased susceptibility is associated with genetic factors and the way certain populations metabolize medications. Research has shown that Black patients are more likely to experience angioedema compared to other ethnic groups when taking ACE inhibitors, which are commonly prescribed for hypertension and heart failure.

Angioedema is a potentially serious condition characterized by rapid swelling of the dermis, subcutaneous tissue, and mucosal tissues. The risk associated with ACE inhibitors can be attributed to their mechanism of action, which influences the renin-angiotensin-aldosterone system. The resulting accumulation of bradykinin, a peptide that increases vascular permeability, plays a significant role in the development of angioedema.

While angioedema does occur among individuals of all ethnic backgrounds, the heightened prevalence and severity in Black individuals necessitate careful monitoring when these medications are prescribed. This understanding allows healthcare providers to make informed decisions about treatment options and patient management.